| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |